poisar

Stocks · News reference

Werewolf Therapeutics Announces All-Stock Merger With Ambros Therapeutics At Implied Values Of $500M For Ambros, $47.5M For Werewolf; Concurrent $150M Private Placement, Werewolf Holders To Own About 6.8%

BenzingaAug 21, 2026, 12:01 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 21, 2026, 12:01 PM
Checked
Aug 21, 2026, 12:01 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading